The benefits and risks of alemtuzumab in multiple sclerosis. (March 2013)
- Record Type:
- Journal Article
- Title:
- The benefits and risks of alemtuzumab in multiple sclerosis. (March 2013)
- Main Title:
- The benefits and risks of alemtuzumab in multiple sclerosis
- Authors:
- Ontaneda, Daniel
Cohen, Jeffrey A - Abstract:
- Is Part Of:
- Expert review of clinical immunology. Volume 9:Number 3(2013)
- Journal:
- Expert review of clinical immunology
- Issue:
- Volume 9:Number 3(2013)
- Issue Display:
- Volume 9, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 9
- Issue:
- 3
- Issue Sort Value:
- 2013-0009-0003-0000
- Page Start:
- 189
- Page End:
- 191
- Publication Date:
- 2013-03
- Subjects:
- alemtuzumab -- efficacy -- multiple sclerosis -- risk
Clinical immunology -- Periodicals
616.079 - Journal URLs:
- http://www.tandfonline.com/toc/ierm20/current ↗
http://www.future-drugs.com/loi/eci ↗
http://informahealthcare.com ↗ - DOI:
- 10.1586/eci.13.1 ↗
- Languages:
- English
- ISSNs:
- 1744-666X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002985
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 15397.xml